Molecular Cancer Biology
A section of Cancers (ISSN 2072-6694).
Section Information
Dysregulation of the complex biological processes that control cell and tissue homeostasis, growth and development under physiological conditions is the key driver of oncogenesis, tumor progression and therapy resistance of cancer. A better understanding of the pivotal molecular events underlying these three aspects of cancer biology will aid the identification of novel targets and the development of new therapeutic approaches for the treatment of this devastating disease. This section covers all aspects of molecular and cellular biology related to the development, progression and therapy of cancer. Topics of interest include:
- oncogenesis and cancer progression;
- cancer immunology;
- drug discovery and targeted therapy;
- tumor invasion and metastasis;
- cancer stem cell biology;
- genomic instability;
- DNA damage and repair;
- cell cycle regulation;
- hypoxia;
- cancer cell metabolism;
- mechanisms of therapy resistance;
- autophagy;
- apoptosis;
- necrosis;
- senescence;
- angiogenesis;
- inflammation and cancer
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Clinical Features and Molecular Pathology of Melanomas (Deadline: 15 September 2024)
- Hodgkin Lymphoma (Volume II) (Deadline: 15 September 2024)
- The Duality of MYB: Normal and Cancer Cell Functions (Deadline: 20 September 2024)
- Tumor Necrosis Factor: Molecular Insights and Clinical Implications (Volume II) (Deadline: 30 September 2024)
- Rhabdomyosarcoma: Still Unresolved Questions but New Perspectives (Deadline: 30 September 2024)
- The Role of Chromosomal Instability in Cancer (Deadline: 30 September 2024)
- Comprehensive Genomic Profiling for Metastatic Breast Cancer: Current Status and Future Perspectives (Deadline: 30 September 2024)
- Sex Differences in Cancer (Deadline: 15 October 2024)
- Growth Factors and Receptor Tyrosine Kinases in Development, Regeneration, and Tumorigenesis (Deadline: 15 October 2024)
- Emerging Insights into Cell Death in Cancer (Deadline: 25 October 2024)
- Diagnostics and Therapeutics Advances in Pancreatic Cancer (Deadline: 30 October 2024)
- The Analysis of Circulating Tumor Cells (CTCs): New Insights into the Biology of Cancers (Deadline: 31 October 2024)
- Transcription Factors in Breast Cancer (Deadline: 31 October 2024)
- Microtubule-Associated Proteins (MAPs) and Cancers (Deadline: 31 October 2024)
- Updates on the Molecular Profile of Gastrointestinal Stromal Tumors (Volume II) (Deadline: 31 October 2024)
- Oxidative Stress and Cancer: Possible Beneficial and Antioxidant Strategies (Volume II) (Deadline: 15 November 2024)
- Molecular and Genetic Diagnosis and Targeted Therapy of Myeloproliferative Neoplasms (Deadline: 15 November 2024)
- Molecular Mechanisms in Head and Neck Cancer (Deadline: 15 November 2024)
- Molecular Pathways in Cancers (Deadline: 15 November 2024)
- Mitochondrial Uncoupling and Cancer (Deadline: 23 November 2024)
- Advances in Genetic and Molecular Approaches to Skin Cancer (Deadline: 25 November 2024)
- Updates on the Genetics of Myeloid Malignancies (Deadline: 25 November 2024)
- Rare Gynecological Cancers (Deadline: 25 November 2024)
- Lung Cancer: Molecular Pathways, Current Therapies and New Targeted Treatments (Deadline: 30 November 2024)
- Exploring the Genetic and Epigenetic Factors in Leukemia and Lymphoma (Deadline: 30 November 2024)
- Natural Compounds in Cancers (Deadline: 30 November 2024)
- Novel Insights in Ocular and Orbital Oncology: From Molecular Biology to Treatment Strategies (Deadline: 30 November 2024)
- Lung Cancer—Molecular Insights and Targeted Therapies (Volume II) (Deadline: 30 November 2024)
- Genomics of Hematologic Cancers (Volume II) (Deadline: 30 November 2024)
- Advances in Molecular Oncology and Therapeutics (Deadline: 30 November 2024)
- Oncogenesis of Lymphoma (Deadline: 30 November 2024)
- MAPK/Akt Signaling Pathways: Function, Regulation, Signaling, and Implications for Cancer Treatment (Deadline: 30 November 2024)
- Blood Stem Cell and Hematological Malignancies (Deadline: 30 November 2024)
- Cutaneous Lymphoma (Deadline: 1 December 2024)
- The 10th International MDM2 Workshop—Opening Up New Avenues for MDM2 and p53 Research (Deadline: 10 December 2024)
- Molecular Targeted Therapy in Cancer (Deadline: 15 December 2024)
- Urology Cancers: Drug Resistance and Signaling Mechanism (Deadline: 15 December 2024)
- Mechanisms of mRNA Translation in Pancreatic Cancer (Deadline: 15 December 2024)
- Technological Development for Advances in Cancer Research and Precision Oncology (Deadline: 23 December 2024)
- Mantle Cell Lymphoma: From Biology to Therapy (Deadline: 25 December 2024)
- Alternative Cell Death Modes in Regulating Cancer Stem Cells and Therapeutic Strategies (Deadline: 25 December 2024)
- Thioredoxin and Glutathione Systems in Glioblastoma: Mechanisms, Challenges and Targeting Opportunities (Deadline: 31 December 2024)
- Precision Oncology for Rare Skin Cancers (Deadline: 31 December 2024)
- Molecular Genetics, Signaling Pathways, and Therapeutic Strategies for Liver Cancer (Deadline: 31 December 2024)
- Genomic Alterations in Leukemia (Volume II) (Deadline: 31 December 2024)
- EGFR Signaling in Cancer (2nd Edition) (Deadline: 31 December 2024)
- Lung Cancer Proteogenomics: New Era, New Insights (Deadline: 15 January 2025)
- Hypoxic Signaling: Relation to Cancer Progression and Cancer Stem Cell Regulation (Deadline: 15 January 2025)
- Cell Biology of Cancer Invasion (Deadline: 15 January 2025)
- Significance of KRAS Gene Mutations in Colorectal Cancer (Deadline: 25 January 2025)
- Molecular Genomics in Brain Tumors (Deadline: 31 January 2025)
- Molecular Pathogenesis of Liver Cancers (Deadline: 31 January 2025)
- Multiple Signaling Pathways in Ovarian Cancer (Deadline: 31 January 2025)
- The Role of Regulatory Non-Coding RNA in Cancer (Deadline: 31 January 2025)
- Alterations in Ribosome Structure, Integrity and Function in Cancer and in Response to Cancer Treatments (Deadline: 31 January 2025)
- Molecular Biology, Diagnosis and Management of Thyroid Cancer (Deadline: 15 February 2025)
- The Role of Apoptosis and Autophagy in Cancer (Deadline: 28 February 2025)
- New Insights into Cell Death and Drug Resistance in Cancer (Deadline: 28 February 2025)
- Advances in Personalized Medicine of Cancers (Deadline: 28 February 2025)
- Cell Migration and Invasion in Cancer (Deadline: 28 February 2025)
- Recent Advances in the Molecular Genetics of Sarcomas (Deadline: 1 March 2025)
- Incorporating DNA Damage Response (DDR) Mechanisms in Cancer Systems: 2nd Edition (Deadline: 15 March 2025)
- Cytokine and Growth Factor Signaling at the Interface between Immune Cells and Cancer (Deadline: 15 March 2025)
- Oxidative Phosphorylation System Dysfunction Role and Mechanisms in Cancer and Its Therapies (Deadline: 20 March 2025)
- Recent Advances in Genetic Studies on Leukemia (Deadline: 30 March 2025)
- Molecular Biology of Urological Cancers (Deadline: 31 March 2025)
- The Role of Ferroptosis in Cancer (Deadline: 31 March 2025)
- Calcium Signaling in Cancer Cell Progression (Deadline: 31 March 2025)
- Intratumoral Heterogeneity in Brain Cancers (Deadline: 31 March 2025)
- Hormones and Tumors (Deadline: 31 March 2025)
- Cervical Cancer: Study on Molecular Landscape and Protein Biomarkers. Current Diagnostic and Therapeutic Capabilities (Deadline: 15 April 2025)
- Advances in Imaging Techniques of Molecular Oncology (Deadline: 15 April 2025)
- Advances in Genomics and Molecular Diagnostics in Gynecological Pathology (Deadline: 15 April 2025)
- Clinical Applications of Integrative Analysis of Validated Somatic and Germline Genomic Results in Oncology (Deadline: 25 April 2025)
- The Metabolic Landscape of Gynecological Cancer: Identifying Targets for Therapeutic Intervention (Deadline: 28 April 2025)
- Molecular Pathology of Brain Tumors (Deadline: 30 April 2025)
- Advancements in Molecular Research of Prostate Cancer (Deadline: 30 April 2025)
- Advances in Uveal Melanoma (Deadline: 30 April 2025)
- Identification and Clinical Application of Immunological Receptors Targeting Mutated Antigens Expressed by Solid Tumors (Volume II) (Deadline: 5 May 2025)
- Neuroblastoma: Molecular Insights and Clinical Implications (Deadline: 15 May 2025)
- Molecular Alterations of Endometrial Cancer (Deadline: 20 May 2025)
- MicroRNA (miRNA) in Cancers (Deadline: 31 May 2025)
- Genetic and Epigenetic Heterogeneity in Cancer (Deadline: 31 May 2025)
- Molecular Insights into Drug Resistance in Cancer (Deadline: 31 May 2025)
- Cell Adhesion in Human Cancer (Deadline: 31 May 2025)
- The Cancer Stem Cells and the Quiescence (Deadline: 31 May 2025)
- Signaling Pathways Influencing Cancer Cell Proliferation and Dormancy States (Deadline: 15 June 2025)
- Application of Large-Scale Genome Data in Identifying Clinically Actionable Targets in Cancer (Deadline: 15 June 2025)
- Advances in Molecular and Genetic Biomarkers in Head and Neck Squamous Cell Carcinoma (Deadline: 24 June 2025)
- Looking for New Biochemical Mechanisms in Cancer: The New Dawn in the Omics Sciences (Deadline: 26 June 2025)
- Advancements and Treatment Strategies for Central Nervous System Malignancies and Cancer Stem Cells (Deadline: 30 June 2025)
- Precision Medicine in Thoracic Oncology (2nd Edition) (Deadline: 30 June 2025)
- How Ubiquitin and Ubiquitination Affect Cancer Progression (Deadline: 30 June 2025)
- Molecular Mechanisms in Bone and Soft Tissue Sarcomas (Deadline: 30 June 2025)
- Novel Advances in the Molecular Understanding of Myeloproliferative Neoplasms (MPNs) (Deadline: 30 June 2025)
- Advances in Neurofibromatosis (Deadline: 5 July 2025)
- Molecular Biology, Diagnosis and Management of Endometrial Cancer (Deadline: 12 July 2025)
- Exploiting Liabilities in Mechanism of DNA Repair for Cancer Therapy (Deadline: 31 July 2025)
- Cancer Induced Organ Dysfunctions (Cachexia) (Deadline: 31 July 2025)
- Molecular and Cellular Heterogeneity in an Evolving Tumor Landscape: When Diversity Gives Rise to Aggressive and Drug-Resistant Cells (2nd Edition) (Deadline: 31 July 2025)
- Cancer Genetics and Epigenetics: Their Roles and Clinical Implications (Deadline: 15 September 2025)
- Giant-Cell-Containing Tumors of Bone—New Insights into Pathobiology, the Clinical Setting and Targeted Therapies (Deadline: 30 September 2025)
- Feature Review Paper Special Issue in Section Molecular Cancer Biology (Deadline: 30 September 2025)
- Molecular Biology, Diagnosis and Management of Cervical Cancer (Deadline: 31 December 2025)
Topical Collections
Following topical collections within this section are currently open for submissions:
- Prostate Cancer—from Molecular Mechanisms to Clinical Care
- Recent Advances in Pancreatic Ductal Adenocarcinoma
- Regulatory and Non-Coding RNAs in Cancer Epigenetic Mechanisms
- Role of Stromal Cells in Determining Tumor and Cancer Stem Cell Behaviors and Therapeutic Response
- Stemness and Drug-Persistence in Cancer
- Tumor Evolution: Progression, Metastasis and Therapeutic Response
